Project Information

Category:

Industry:

Client:

MedTech Company (name anonymised)

Review:

Discreet white-label partnership, (Client Confidential)

Share to:

Life Sciences (Canada Regulatory)

Entering Canada’s complex and regionally fragmented healthcare system requires more than innovation, it demands a precise strategy. DRG helped a global diagnostics provider navigate regulatory requirements, map reimbursement pathways, and uncover critical market insights.

Desk Research Group was engaged by an international diagnostics provider exploring market entry into Canada with a medical device. The project aimed to deliver a comprehensive understanding of the regulatory, reimbursement, procurement, and competitive landscape across four provinces.

Overview

Names used in this case study are not the actual company names, as the information is protected under a Non-Disclosure Agreement (NDA).

BACKGROUND

The client sought to validate the commercial opportunity and navigate the complexities of the Canadian healthcare environment. Key objectives included:

  • Assessing the regulatory classification of their diagnostic device at the federal level
  • Mapping reimbursement policies and funding pathways in Ontario, Quebec, Alberta, and British Columbia
  • Gaining competitive intelligence on incumbent and emerging diagnostic solutions
  • Evaluating procurement mechanisms and opportunities for provincial integration

DRG conducted an in-depth review of open-source data, regulatory guidance, provincial funding models, and competitive benchmarks. Our approach covered:

  • Analysis of Health Canada medical device regulations, including potential pathways for licence amendments
  • Provincial-level assessment of public reimbursement schemes and coverage variability
  • Identification of market needs driven by projected increases in disease burden
  • Review of competitor positioning and clinical integration models

Outcomes

Our research confirmed federal and provincial guidelines, and device licence amendments as future indications evolve.

It mapped procurement models, including Alberta’s single health authority system, Quebec’s consolidated purchasing approch and Ontario’s decentralised hospital-led model.

Benchmarked leading technologies, including emerging alternatives, and AI-driven tools, identifying gaps and opportunities.

Outlined pathways for clinical adoption, including entry through teaching hospitals and potential expansion into primary care.

Entering Canada’s regional health-care maze without a roadmap can stall even the best technology. The engagement armed our client with the clarity, connections, and phased actions they needed to consider, and refine tactics with the evolving market.

Our research highlighted differentiators such as portability, total cost of ownership, and AI-ready data outputs, allowing the client to frame value in procurement discussions without naming rivals directly. It summarised the key purchasing structures, from single-authority systems to decentralised hospital models, and recommended engagement sequences to align with each province’s buying cycle. Finally, it delivered province-by-province guidance on coverage gaps and fast-track opportunities, including practical levers to close funding shortfalls in regions where public reimbursement is limited.

More DRG Case Study Spotlights:

When you are ready to make your next move, we are here to help you make it with clarity and confidence.

Get In Touch
+1 416-271-5424

Let’s Talk

Canada | United States | United Kingdom | Spain

Our Reach

When you are ready to make your next move, we are here to help you make it with clarity and confidence.

Get In Touch
+1 416-271-5424

Let’s Talk

Canada | United States | United Kingdom | Spain

Our Reach